• Molecular NameAnisindione
  • SynonymAnisin indandione
  • Weight252.269
  • Drugbank_IDDB01125
  • ACS_NO117-37-3
  • Show 3D model
  • LogP (experiment)2.9
  • LogP (predicted, AB/LogP v2.0)2.93
  • pka4.1
  • LogD (pH=7, predicted)-0.21
  • Solubility (experiment)0.0798 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-4.39
  • LogSw (predicted, AB/LogsW2.0)0.02
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors0
  • No.of HBond Acceptors3
  • No.of Rotatable Bonds2
  • TPSA43.37
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA synthetic anticoagulant and an indanedione derivative.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityAn overdose is likely to cause abnormal bleeding, for which the symptoms include: bleeding from gums or nose, blood in urine or stools, excessive bleeding from minor cuts, patches of discoloration or bruises on the skin.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A